Vincent Hingot

Vincent Hingot is an accomplished leader in the biotechnology and pharmaceutical industries with extensive experience in vaccine manufacturing and supply operations. Currently serving as President of the Drug Substance Division at Thermo Fisher Scientific since June 2022, Hingot oversees financial and market performance while executing strategic initiatives with the leadership team. Prior to this, Hingot held multiple senior roles at Sanofi Pasteur, including Senior Vice President of Global Industrial Operations, where responsibilities included managing the production of over 1 billion vaccine doses annually and overseeing a global network of manufacturing sites. Hingot's career also includes significant positions at GlaxoSmithKline Biologicals, where leadership in vaccine manufacturing and operational excellence was paramount. With a Master of Engineering in Biotechnology from Meurice Chimie, Hingot's background encompasses expertise in industrial operations, project management, and process optimization in the biopharmaceutical sector.